Cookies on this website

We use cookies to ensure that we give you the best experience on our website. If you click 'Accept all cookies' we'll assume that you are happy to receive all cookies and you won't see this message again. If you click 'Reject all non-essential cookies' only necessary cookies providing core functionality such as security, network management, and accessibility will be enabled. Click 'Find out more' for information on how to change your cookie settings.

Publications

Clinical antiviral efficacy of favipiravir in early COVID-19 (PLATCOV): an open-label, randomised, controlled, adaptive platform trial

Luvira V. et al, (2024), BMC Infectious Diseases, 24

Expanding the roles of community health workers to sustain programmes during malaria elimination: a meeting report on operational research in Southeast Asia

Dysoley L. et al, (2024), Malaria Journal, 23

Antiviral efficacy of molnupiravir versus ritonavir-boosted nirmatrelvir in patients with early symptomatic COVID-19 (PLATCOV): an open-label, phase 2, randomised, controlled, adaptive trial

Schilling WHK. et al, (2024), The Lancet Infectious Diseases, 24, 36 - 45

Comparing the roles of community health workers for malaria control and elimination in Cambodia and Tanzania

Adhikari B. et al, (2023), BMJ Global Health, 8, e013593 - e013593

Expanding the role of village malaria workers in Cambodia: Implementation and evaluation of four health education packages

Betrian M. et al, (2023), PLOS ONE, 18, e0283405 - e0283405

The feasibility of novel point-of-care diagnostics for febrile illnesses at health centres in Southeast Asia: a mixed-methods study

Adella FJ. et al, (2023), Transactions of The Royal Society of Tropical Medicine and Hygiene

Community engagement among forest goers in a malaria prophylaxis trial: implementation challenges and implications

Conradis-Jansen F. et al, (2023), Malaria Journal, 22

Expanding the role of village malaria workers in Cambodia: implementation and evaluation of four health education packages

Betrian M. et al, (2023)

Glucose-6-Phosphate Dehydrogenase (G6PD) Measurement Using Biosensors by Community-Based Village Malaria Workers and Hospital Laboratory Staff in Cambodia: A Quantitative Study.

Adhikari B. et al, (2023), Pathogens (Basel, Switzerland), 12

Pharmacometrics of high-dose ivermectin in early COVID-19 from an open label, randomized, controlled adaptive platform trial (PLATCOV)

Schilling WHK. et al, (2023), eLife, 12

Effectiveness of community engagement among forest goers in a malaria prophylaxis trial: Implementation challenges and implications

Conradis-Jansen F. et al, (2023)

Village malaria workers for the community-based management of vivax malaria

Adhikari B. et al, (2023), The Lancet Regional Health - Southeast Asia, 9, 100128 - 100128

Antimalarial chemoprophylaxis for forest goers in southeast Asia: an open-label, individually randomised controlled trial

Tripura R. et al, (2023), The Lancet Infectious Diseases, 23, 81 - 90

Ten-year persistence and evolution of Plasmodium falciparum antifolate and anti-sulfonamide resistance markers pfdhfr and pfdhps in three Asian countries

Srisutham S. et al, (2022), PLOS ONE, 17, e0278928 - e0278928

Field evaluation of the diagnostic performance of EasyScan GO: a digital malaria microscopy device based on machine-learning

Das D. et al, (2022), Malaria Journal, 21

Good participatory practice for coronavirus disease 2019 (COVID-19) research: the case of a COVID-19 prevention study

Perrone C. et al, (2022), Wellcome Open Research, 6, 216 - 216

Good participatory practice for coronavirus disease 2019 (COVID-19) research: the case of a COVID-19 prevention study

Perrone C. et al, (2022)

Clinical antiviral efficacy of remdesivir and casirivimab/imdevimab against the SARS-CoV-2 Delta and Omicron variants

Jittamala P. et al, (2022)

Glucose 6 Phosphate Dehydrogenase (G6PD) quantitation using biosensors at the point of first contact: a mixed method study in Cambodia

Adhikari B. et al, (2022), Malaria Journal, 21

Pharmacometric assessment of the in vivo antiviral activity of ivermectin in early symptomatic COVID-19

Schilling WHK. et al, (2022)

Load More

Include forthcoming?